{"type":"analysis","id":"analysis:research-radical-numerics-ai-phage-first-is-real-as-a-claim-but-the-fda-and-outcome","slug":"research-radical-numerics-ai-phage-first-is-real-as-a-claim-but-the-fda-and-outcome","title":"Radical Numerics' AI-phage \"first\" is real as a claim, but the FDA and outcome details are unverified","description":"The company says an Omnii-1-designed phage cocktail reached one patient under compassionate use. Its own written materials never name the FDA, no outcome is disclosed, and the clinical work is not peer-reviewed.","published_at":"2026-11-08T23:00:00.000Z","updated_at":"2026-11-08T23:00:00.000Z","record_date":"2026-11-08","topics":["design","research"],"source_urls":["https://www.radicalnumerics.ai/blog/omnii-phage","https://www.financialcontent.com/article/bizwire-2026-10-20-radical-numerics-launches-omnii-1-a-new-generation-of-biological-ai-as-first-ai-designed-phage-therapy-reaches-human-patient","https://propakistani.pk/2026/10/22/scientists-use-ai-designed-viruses-to-treat-human-patient/","https://time.news/radical-numerics-injects-first-ai-designed-virus-into-human-patient/","https://www.radicalnumerics.ai/blog/omnii-1","https://fortune.com/2026/06/15/exclusive-ai-dna-radical-numerics-eric-nguyen-biology-biodefense-drug-discovery/","https://finance.yahoo.com/technology/ai/articles/radical-numerics-launches-omnii-1-162200809.html"],"language":"en","routes":{"html":"https://newruntime.com/analysis/research-radical-numerics-ai-phage-first-is-real-as-a-claim-but-the-fda-and-outcome/","markdown":"https://newruntime.com/analysis/research-radical-numerics-ai-phage-first-is-real-as-a-claim-but-the-fda-and-outcome.md","json":"https://newruntime.com/analysis/research-radical-numerics-ai-phage-first-is-real-as-a-claim-but-the-fda-and-outcome.json"},"author":{"role":"author","name":"Andrey Reshetnikov","profile":"https://newruntime.com/owner-profile.md","profile_json":"https://newruntime.com/owner-profile.json","same_as":["https://www.linkedin.com/in/reshetnikov1/","https://t.me/lapetuse"]},"editorial_provenance":{"desk":"authorial","target_ref":"deep_research:12d1f175-1056-4231-9798-baa99743b56f","authorial_article_id":"12d1f175-1056-4231-9798-baa99743b56f"},"next_reads":[{"type":"collection","path":"/analysis/","url":"https://newruntime.com/analysis/","title":"Analysis","reason":"Open the latest authorial analysis.","media_type":"text/html","json_url":"https://newruntime.com/analysis.json"},{"type":"collection","path":"/sources/","url":"https://newruntime.com/sources/","title":"Sources","reason":"See the original sources this archive cites.","media_type":"text/html"}]}